Skip to content
Patagonia launches sweet new down coat made with bio-material
Louisiana sugar cane replaces crude oil in a down hoody coat that keeps ...
Read More
Start-up Stadium introduces biotech innovators and investors
Start-ups looking to present their innovations in front of the biggest annual gathering ...
Read More
Climate change makes us sicker, finds review of insurance claims
A new study based on insurance claims found that the consistently rising temperatures ...
Read More
The 30-year-old 340B drug discount program is due for reform
At 30-years old, the 340B program is buckling under its own weight and ...
Read More
AGT says gene therapy is a ‘potential cure’ for HIV
American Gene Technologies (AGT) calls its gene therapy, AGT103-T, a “potential cure” for ...
Read More
Novavax announces phase 2 trial for combined COVID/flu vaccine
Novavax, a biotech company dedicated to developing and commercializing next-generation vaccines for serious ...
Read More
EDITORS' CHOICE
BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO President ...
Read More
LATEST NEWS
BIO's View
Nearly half of Americans say insurers’ rules on access delayed, denied, or altered care
Americans are frustrated with the health care system for two reasons. First, it costs too much. But—second—it provides too little. While most of the dialogue ...
BIO Events
BIG Summit: Experts see signs of M&A momentum in 2026
We could be in for another big year of biotech M&A. A busy 2025, in both licensing and M&A in biopharma, saw over 4,000 deals ...
BIO Events
BIG Summit: Seeking opportunities while navigating risks of global trade
China is becoming an increasingly influential player in the global biotech market. More than a third of U.S. licensing deals this year have involved assets ...
Federal Policy
BIO Patient Advocacy Coffee Chat: Act now to be heard on CMS drug pricing
The Medicare drug price “negotiation” process has entered its third year, with some evolution but continued complexity for patients and patient organizations. This year, 15 ...
BIO Events
Meet us in Miami for the BIO Investment and Growth Summit
The inaugural Biotechnology Innovation Organization (BIO) Investment and Growth (BIG) Summit kicks off on March 2, 2025, and will convene industry leaders in sunny Miami ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
Charlotte emerging as a global leader in health care innovation and med tech
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another ...
Read More
International
Bio's View
Nearly half of Americans say insurers’ rules on access delayed, denied, or altered care
Americans are frustrated with the health care system for two reasons. First, it costs too much. But—second—it provides too little. ...
Read More
